Connor, Clark & Lunn Investment Management (CC&L)’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495K | Buy |
+122,927
| New | +$495K | ﹤0.01% | 1258 |
|
|
2024
Q2 | – | Sell |
-55,634
| Closed | -$159K | – | 1394 |
|
|
2024
Q1 | $159K | Sell |
55,634
-101,826
| -65% | -$290K | ﹤0.01% | 1423 |
|
|
2023
Q4 | $556K | Buy |
157,460
+102,315
| +186% | +$361K | ﹤0.01% | 1020 |
|
|
2023
Q3 | $143K | Buy |
55,145
+33,258
| +152% | +$86.1K | ﹤0.01% | 1268 |
|
|
2023
Q2 | $86.2K | Buy |
+21,887
| New | +$86.2K | ﹤0.01% | 1249 |
|